Related Experiment Video
Updated: May 25, 2025
Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
Pectolinarin Promotes Functional Recovery after Spinal Cord Injury by Regulating Microglia Polarization Through the
Chenggui Wang1,2, Jiawei Li1,2, Chenyu Wu1,2
1Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Abstract:
After spinal cord injury (SCI), microglia polarization plays an important role in spinal cord recovery and axon regeneration. In this study, we conducted mRNA microarrays to identify genes associated with different microglial phenotypes. The results showed a correlation between microglial polarization and the PI3K/AKT signaling pathway, a key regulator of inflammatory responses. In addition, we found that Pectolinarin (PTR) could effectively inhibit lipopolysaccharide (LPS)-induced M1 polarization of microglia and facilitate their transition to the M2 phenotype by directly suppressing the PI3K/AKT signaling pathway. In our established animal model of SCI, it was confirmed that PTR treatment induced microglial polarization towards the M2 phenotype, resulting in reduced fibrous scar formation, enhanced myelin reconstitution, and improved axonal regeneration. In conclusion, targeting the PI3K/AKT signaling pathway with PTR presents a promising new direction for SCI treatment.
Insights
Pectolinarin (PTR) promotes spinal cord recovery after injury by shifting microglia to a beneficial M2 phenotype. This treatment suppresses the PI3K/AKT pathway, reducing inflammation and enhancing axon regeneration.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia polarization is crucial for spinal cord injury (SCI) recovery and axon regeneration.
- Identifying genes linked to microglial phenotypes can reveal therapeutic targets.
Purpose of the Study:
- To investigate the role of microglia polarization in SCI.
- To explore Pectolinarin (PTR) as a potential therapeutic agent for SCI by targeting microglial polarization and the PI3K/AKT pathway.
Main Methods:
- Conducted mRNA microarrays to identify genes associated with microglial phenotypes.
- Utilized an in vitro model to assess PTR's effect on lipopolysaccharide (LPS)-induced M1 microglia polarization.
- Employed an animal model of SCI to evaluate PTR treatment's efficacy.
Main Results:
- A correlation was found between microglial polarization and the PI3K/AKT signaling pathway.
- PTR inhibited LPS-induced M1 microglia polarization and promoted M2 phenotype transition by suppressing the PI3K/AKT pathway.
- In an SCI animal model, PTR treatment led to M2 microglia polarization, reduced scar formation, improved myelin repair, and enhanced axonal regeneration.
Conclusions:
- Targeting the PI3K/AKT signaling pathway with PTR is a promising therapeutic strategy for SCI.
- PTR facilitates microglial polarization towards a neuroprotective M2 phenotype, aiding spinal cord repair.
More Related Videos
11:57Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
09:08A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury
Published on: September 13, 2018
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
01:20The JAK-STAT Signaling Pathway